GF CSI Medical Service ETF (560260) Rises 3.72%, Latest AUM Reaches 1.484 Billion Yuan

NewTimeSpace News, as of 10:17 on May 21, 2026, GF Medical ETF (560260) rose 3.72%, with its latest quoted price at 0.84 yuan. (The stocks listed above are merely index constituents and do not constitute any specific recommendation.)

In terms of liquidity, GF Medical ETF recorded an intraday turnover rate of 0.32%, with a trading volume of 4.8714 million yuan. Over a longer horizon, as of May 20, the ETF's average daily turnover over the past year stood at 11.6747 million yuan.

Regarding scale, the latest AUM of GF Medical ETF reached 1.484 billion yuan. (Data source: Wind)

In terms of return capability, as of May 20, 2026, since its inception, GF Medical ETF achieved a highest single-month return of 29.94%, a longest consecutive gaining streak of five months with a cumulative gain of 24.01%, and an average return of 6.42% during up months. As of May 20, 2026, the ETF's annualized excess return over its benchmark over the past year was 1.52%.

In terms of drawdown, as of May 20, 2026, GF Medical ETF's relative drawdown versus its benchmark since the beginning of the year was 0.07%.

In terms of fees, GF Medical ETF has a management fee rate of 0.50% and a custody fee rate of 0.05%, which are at a relatively low level among comparable funds.

In terms of tracking accuracy, as of May 20, 2026, GF Medical ETF's six-month tracking error was 0.016%, the highest tracking precision among comparable funds.

From a valuation perspective, the latest price-to-earnings ratio (PE-TTM) of the CSI Medical Index, which GF Medical ETF tracks, is only 28.15 times, placing it at the 1.17th percentile over the past year—meaning the valuation is lower than that of over 98.83% of the time in the past year, indicating a historically low level.

GF Medical ETF closely tracks the CSI Medical Index. The CSI Medical Index selects securities of listed companies in the healthcare and pharmaceutical industry whose businesses involve medical themes such as medical devices, medical services, and medical information technology as index constituents, in order to reflect the overall performance of listed company securities in the medical theme.

NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.